April 9, 2018 / 6:09 PM / 4 months ago

BRIEF-Rxi Pharmaceuticals Says $4.9 Mln Registered Direct Offering Priced At-The Market

April 9 (Reuters) - Rxi Pharmaceuticals Corp:

* RXI PHARMACEUTICALS ANNOUNCES $4.9 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

* ENTERED AGREEMENTS FOR PURCHASE OF 1.5 MLN SHARES AT $3.24375/SHARE IN REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

* TO USE PROCEEDS FROM OFFERING TO FUND PRECLINICAL & CLINICAL DEVELOPMENT, OTHER RESEARCH & DEVELOPMENT ACTIVITIES, AMONG OTHERS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below